Germany · 
Who invested in InfalRX?
InfalRX's investors include RA Capital Management, Cormorant Asset Management and Bain Capital Life Sciences.
Germany · Series D startup
Who invested in InfalRX
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$55Mraised across 1 round since 2017, from 1 source
- Latest round
- Series D, $55MOct 2017
- Investors
- 3
The rounds
- Oct 2017Series D$55M
Reported by FinSMEs
Everyone who backed them
Bain Capital Life SciencesPrivate equity1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about InfalRX
How much has InfalRX raised?
InfalRX has raised $55M across 1 round since 2017.
When did InfalRX last raise?
InfalRX's most recent round was a Series D of $55M in Oct 2017.
What was InfalRX's biggest round?
Its most recent round, $55M in Oct 2017, is also its largest on record.
Who backed InfalRX first?
InfalRX's first round on record, in Oct 2017, was backed by RA Capital Management, Cormorant Asset Management and Bain Capital Life Sciences.
What stage is InfalRX at?
InfalRX's latest named round is a Series D, in Oct 2017.
Where is InfalRX based?
InfalRX is based in Germany.
Companies like InfalRX
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.